Illinois News Joint

OCTOBER 13, 2024

Illinois officials recently released the Annual Cannabis Report for Fiscal Year 2024. The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. The Medical Cannabis Advisory Board (MCAB) convened four times in FY24.

Conditions 111

Conditions Education Patients Programs 111

NORML

JANUARY 6, 2023

“Cannabis has established efficacy in the treatment of multiple conditions, including chronic pain, and it possesses a safety profile that is either comparable or superior to other controlled substances. The post Study: Chronic Pain Patients Frequently Report Using Cannabis In Place of Opioids appeared first on NORML.

Chronic Pain 235

Chronic Pain Patients Safety Treatment 235

Project CBD

MARCH 10, 2020

Fibromyalgia is an intractable condition defined by chronic, widespread pain and debilitation. But a recent study published in Clinical and Experimental Rheumatology demonstrated that cannabis can be used effectively to remedy these problems, at least by some patients.

Conditions 361

Conditions Patients Cannabis 361

NORML

NOVEMBER 25, 2019

Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One. Authors reported “an independent negative association between frequent cannabis use and frequent illicit opioid use.”

Chronic Pain 225

Chronic Pain Patients Therapy Data 225

Americans for Safe Access

MARCH 16, 2021

Despite the fact that 36 states have reformed their laws to provide for safe and legal access to cannabis for qualifying patients, veterans living across these states still face a confusing system of federal and state laws regarding physician engagement and affordable access. For example, veterans who rely on the U.S.

Access 342

Access State Laws Conditions Programs 342

NORML

MAY 19, 2020

House lawmakers have overwhelmingly approved two bills to amend the state’s medical marijuana program in a manner that significantly expands patients’ access to cannabis products. The measure establishes regulations permitting the home delivery of medical cannabis products to registered patients.

Access 262

Access Therapy Patients Conditions 262

NORML

NOVEMBER 1, 2019

Those suffering from chronic pain report significant improvements in health following the passage of medical cannabis access laws, according to data published in the journal Forum for Health Economics & Policy. Among state-licensed medical cannabis registrants, two out of three report consuming cannabis to mitigate pain conditions.

Access 185

Access Patients Chronic Pain Law 185

United Patients Group

OCTOBER 25, 2024

Cannabis, commonly known as marijuana, has gained widespread acceptance for both medicinal and recreational use in recent years. However, while cannabis can offer therapeutic benefits and a relaxing recreational experience, it’s important to recognize that for some individuals, regular use can lead to dependency and problematic behavior.

Treatment 98

Treatment Therapy Conditions Consumption 98

NORML

JUNE 6, 2019

Steve Sisolak has signed legislation, Senate Bill 430 , expanding the pool of patients eligible for medical cannabis therapy. The measure allows patients diagnosed with anxiety disorders, autism, chronic pain, opioid dependency, and other conditions to obtain a recommendation for medical cannabis.

Chronic Pain 266

Chronic Pain Therapy Legislation Patients 266

Project CBD

APRIL 17, 2025

Advantages and disadvantages Traditional topicals including water-based lotions and creams and oil-based balms and salves offer a quick onset time, no psychoactivity, and the potential to treat not only aches, pains, and inflammation, but also skin conditions like psoriasis and eczema. A lot of work remains to be done, they write.

Topical 178

Topical Medicine CBD Clinical Trials 178

NORML

APRIL 30, 2020

.” The CDC’s interest in alternative methods of chronic pain management may be of particular significance to many medical cannabis patients. According to state-registry records, “Chronic pain is currently and historically the most common qualifying condition reported by medical cannabis patients (67.5

Chronic Pain 355

Chronic Pain Clinical Trials Data Patients 355

Illinois News Joint

JANUARY 9, 2025

The Illinois Department of Public Health (IDPH), after confirming votes from the Medical Cannabis Advisory Board (MCAB), officially added four new conditions to the list of qualifying debilitating condition for Illinois patients in the Compassionate Use of Medical Cannabis Program.

Conditions 105

Conditions Treatment Chronic Pain Epilepsy 105

Illinois News Joint

OCTOBER 10, 2024

Illinois officials recently released the Annual Cannabis Report for Fiscal Year 2024. The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. The report also touts, as more evidence, Illinois’ $2,007,401,374 in sales during the past fiscal year.

Seed-To-Sale 110

Seed-To-Sale Data Dispensary Agriculture 110

Illinois News Joint

JUNE 10, 2024

The Illinois Department of Public Health (IDPH), in conjunction with the Medical Cannabis Advisory Board (MCAB), hosted its June meeting from 3-5 p.m. MCAB members voted to recommend Uterine Fibroid and Painful Uterine Fibroid but did not recommend Generalized Anxiety as a qualifying debilitating condition.

Conditions 116

Conditions Education Dispensary Safety 116

NORML

JULY 30, 2020

The most significant new measure, House Bill 819, expands the discretion of physicians so that they can recommend cannabis therapy for “any condition” that they consider “debilitating to an individual patient.”. The post Louisiana: Medical Cannabis Expansion Laws Take Effect appeared first on NORML.

Law 246

Law Therapy Conditions Patients 246

The Cannigma

MARCH 18, 2021

The majority of people with Parkinson’s disease in the United States have not used cannabis to treat their symptoms due to a lack of scientific evidence about its effectiveness. Of those who have used cannabis, most did not receive a recommendation from a doctor or instructions on how to use it, according to the findings of a recent study.

Patients 145

Patients Clinical Trials Treatment Cannabis 145

Illinois News Joint

MAY 12, 2024

The Illinois Department of Public Health (IDPH), in conjunction with the Medical Cannabis Advisory Board (MCAB), hosted its third meeting Monday, May 13. Members again voted unanimously to include FOD as a qualifying debilitating condition for medical cannabis patients in Illinois.

Conditions 105

Conditions Chronic Pain Patients Medicine 105

Illinois News Joint

JULY 31, 2024

During the last few months, the Illinois Department of Public Health (IDPH), in conjunction with the Medical Cannabis Advisory Board (MCAB), voted to add four new recommended conditions to list of qualifying debilitating condition for Illinois patients in the Compassionate Use of Medical Cannabis Program.

Conditions 105

Conditions Chronic Pain Patients Epilepsy 105

The Fresh Toast

JUNE 23, 2022

Study: Inhaled Cannabis May Improve Quality Of Life For Chronic Pain Patients. The administration of aerosolized cannabis through an inhaler may reduce long-term pain in patients with neuropathy and other chronic conditions.

Chronic Pain 133

Chronic Pain Patients Conditions Cannabis 133

The Cannigma

MARCH 25, 2021

Like many people who are drawn to work with and advocate for medical cannabis , I first saw the difference that cannabis can make with someone very close to me. The more I read about it, the more I became fascinated with the chemistry and potential of cannabis. I remain in awe of these patients to this day.

Patients 145

Patients Clinical Trials Medicine Events 145

LifeCannMD

JANUARY 31, 2025

Fernando Fandio-Sende has had countless conversations with patients with autoimmune conditions. We’re aware that each person’s medical condition presents unique challenges with can be deeply personal. Dr. Sende offers Medical Marijuana recommendations for patients with one of Floridas qualifying conditions.

Conditions 97

Conditions Research and Development Treatment Patients 97

Illinois News Joint

NOVEMBER 25, 2024

December 2022, I published a 6-part series titled, “What Illinois cannabis patients really want” to start a dialogue about the large gap between patients’ needs, wishes, concerns, and recommendation for improving the Medical Cannabis Patient Program (MCPP) and the actual amendments to the law legislators have introduced.

Patients 105

Patients Legislation Dispensary Cannabis 105

Project CBD

FEBRUARY 1, 2023

Anyone who has paid any attention to the cannabis “wellness” industry in recent years — whether through state medical and recreational programs or the free-for-all national CBD market — will be familiar with cannabinoid-infused topicals marketed to treat minor aches and pains. Suffice to say, they are thorough.

Conditions 130

Conditions THC CBD Cannabinoids 130

CannaMD

MARCH 9, 2025

A 2020 survey of research literature cites more than 300 studies devoted to the relationship of cannabis to tinnitus. Cannabis is a popular option for patients suffering from tinnitus, and there are a lot of anecdotal reports on marijuana's therapeutic effects on this condition. But that's not the whole story.

Marijuana 108

Marijuana Sleep Conditions Topical 108

LifeCannMD

APRIL 30, 2025

#image_title First-time Medical Marijuana patient in Miami? Miami’s Medical Marijuana Market Getting started with medical marijuana in Miami can be confusing with the amount of cannabis products, consumption rules, and unfamiliar budtender terminology. Did you just receive your Florida medical marijuana card?

Patients 52

Patients Dispensary Marijuana Tincture 52

NORML

JUNE 1, 2020

House and Senate lawmakers have approved a series of bills to facilitate patients’ access to medical cannabis products. ” Under the current law, doctors may only recommend medical cannabis products to those patients with a limited number of select conditions, such as HIV and cancer. John Bel Edwards.

Access 211

Access Therapy Legislation Patients 211

Veriheal

MARCH 27, 2025

In January, a bill was introduced regarding Iowas medical cannabis program, allowing vaporized cannabis to be added to the state-approved Tetrahydrocannabinol ( THC) products list. If passed, vaporizable dried raw cannabis would be included with the products available to Iowas medical patients.

Chronic Pain 72

Chronic Pain Patients THC Programs 72

NORML

APRIL 25, 2019

Doug Burgum signed legislation on Wednesday amending and expanding the state’s nascent medical cannabis access program. House Bill 1283 permits physician assistants to recommend cannabis to qualified patients.

Law 212

Law Therapy Legislation Programs 212

MMJ Recs

MAY 23, 2024

We will be exploring cannabis therapy for chronic conditions. There’s also neuropathic pain, which results from nerve damage, leading to conditions such as shingles or nerve compression. This is where exploring cannabis therapy for chronic conditions enters the picture as a promising alternative.

Conditions 105

Conditions Chronic Pain Therapy Marijuana 105

MMJ Recs

JUNE 29, 2024

Cannabis stands as more than just a plant. For numerous medical marijuana patients throughout the United States with a medicinal marijuana program, it embodies a vital source of relief and healing. It also hinges significantly on proper cannabis storage.

Patients 105

Patients Terpenes Medicine Trichome 105

NORML

MAY 28, 2019

Manufacturing and possessing concentrated forms of cannabis are legally protected activities under the state’s medical cannabis access law, according to a unanimous decision issued today by the Arizona Supreme Court. The decision reverses a 2018 ruling by the Arizona Court of Appeals. ounces of hashish.

Concentrates 213

Concentrates Access Law Legalization 213

CannaMD

AUGUST 4, 2022

As medical marijuana continues to gain acceptance across the United States and beyond, patients are increasingly turning to cannabis-based therapies as a complement or alternative to prescription pharmaceutical drugs.

Patients 141

Patients Therapy Pharmaceutical Marijuana 141

NORML

FEBRUARY 25, 2020

Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinical trial data published in the journal Trauma Surgery & Acute Care. Sixty-six patients participated in the study. Half of the participants received dronabinol and the other half did not.

Clinical Trials 258

Clinical Trials THC Consumption Therapy 258

Illinois News Joint

FEBRUARY 23, 2024

9 House Bill 5633 , which would remove the “requirement that, in order to substantiate a patient’s medical condition, a patient must provide the name of the registered medical cannabis dispensing organization.” HB4465 is basically a protective tax rate amendment for medical patients. Smith introduced on Feb.

Patients 104

Patients Programs Events Cannabis 104

LifeCannMD

MARCH 31, 2025

Fernando Fandino-Sende – Miami’s Top Cannabis Doctor, we understand that seeking medical cannabis treatment is more than a clinical decisionit’s a deeply personal journey toward wellness, often undertaken after considerable reflection and other failed interventions. “Medicine is about science, yesbut healing?

Treatment 80

Treatment Chronic Pain History Conditions 80

NORML

AUGUST 13, 2019

Pritzker (D) has signed two separate medical cannabis expansion bills into law. Senate Bill 455 permits children with serious conditions for which medical marijuana has been recommended to have medical cannabis infused products administered to them while on school property.

Law 183

Law Education Conditions Programs 183

Project CBD

NOVEMBER 11, 2023

NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306